Preparation, characterization and antibacterial activities of chitosan, N-trimethyl chitosan (TMC) and N-diethylmethyl chitosan (DEMC) nanoparticles loaded with insulin using both the ionotropic gelation and polyelectrolyte complexation methods

International Journal of Pharmaceutics
A M M SadeghiH E Junginger

Abstract

TMC and DEMC, quaternized derivatives of chitosan, have been shown to have penetration enhancement properties and able to open the tight junctions of the intestinal epithelia at neutral and alkaline pH environments. The use of the nanoparticulate systems has the advantage of protecting the peptidic drugs from the harsh environment of the gastrointestinal tract. Hence, the aim of this study was to synthesize and characterize TMC and DEMC, both with quaternization degrees of 50+/-5%, which were then used to prepare insulin nanoparticles with two different methods: ionotropic gelation and the polyelectrolyte complexation (PEC) techniques. The obtained nanoparticles were then characterized for size, zeta potential, insulin loading and release as well as antibacterial activities. The results showed that nanoparticles prepared by the PEC method had higher insulin loading efficiency and zeta potential than those made by the ionotropic gelation method and may subsequently be used for further in vitro, ex vivo and in vivo studies. Moreover, the antibacterial studies suggest that the polymers in free form have higher antibacterial activity against Gram-positive bacteria than in the nanoparticulate form.

References

Feb 22, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·H Q MaoK W Leong
Mar 17, 2001·Advanced Drug Delivery Reviews·H TakeuchiY Kawashima
Mar 17, 2001·Advanced Drug Delivery Reviews·K A JanesM J Alonso
May 31, 2002·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Farid A DorkooshHans E Junginger
Jan 4, 2003·Archives of Pharmacal Research·Hyun-Sun ParkSeung-Jin Lee

❮ Previous
Next ❯

Citations

Dec 30, 2008·Journal of Materials Science. Materials in Medicine·V K Mourya, Nazma N Inamdar
Apr 17, 2013·International Journal of Pharmaceutics·Rihab OsmanOya Alpar
Feb 22, 2011·Applied and Environmental Microbiology·Kwang Cheol JeongCharles W Kaspar
Jan 24, 2012·International Journal of Nanomedicine·Yu-Lan HuJian-Qing Gao
May 13, 2014·Carbohydrate Polymers·Thanida ArpornwichanopPramuan Tangboriboonrat
Dec 12, 2012·Advanced Drug Delivery Reviews·Taslim A Al-HilalYoungro Byun
Nov 20, 2012·Advanced Drug Delivery Reviews·Mei-Chin ChenHsing-Wen Sung
Jun 9, 2015·Journal of Microencapsulation·Mehdi Kazemzadeh-NarbatAmyl Ghanem
Jan 20, 2016·International Journal of Pharmaceutics·Yining XuYuan Huang
Nov 18, 2014·International Journal of Molecular Sciences·Alessandro F MartinsEdvani C Muniz
Dec 27, 2011·Colloids and Surfaces. B, Biointerfaces·Oraphan WiarachaiVoravee P Hoven
Jan 19, 2013·International Journal of Pharmaceutics·Angela ViehofAlf Lamprecht
Dec 22, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Min LiuYuan Huang
Sep 8, 2009·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Burcu SayinOya H Alpar
Nov 7, 2015·International Journal of Pharmaceutics·Peiwen ZhangYuan Huang
Dec 11, 2014·Materials Science & Engineering. C, Materials for Biological Applications·Saeid MoghassemiKobra Omidfar
Nov 19, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·A M M SadeghiH E Junginger
Jul 19, 2008·International Journal of Pharmaceutics·V CardileG Cravotto
Mar 3, 2015·Biotechnology Advances·Pedro FonteBruno Sarmento
Jun 28, 2015·International Journal of Biological Macromolecules·Riham R MohamedMagdy W Sabaa
Oct 31, 2012·International Journal of Biological Macromolecules·Jianying HuangChaohua Zhang
Jul 30, 2016·Pharmaceutical Development and Technology·Mayyas Al-RemawiNisrein Jaber
Jan 29, 2017·International Journal of Biological Macromolecules·Riham R MohamedMagdy W Sabaa
Nov 5, 2010·Chemical & Pharmaceutical Bulletin·Kalpana NagpalDina Nath Mishra
Sep 11, 2016·Materials Science & Engineering. C, Materials for Biological Applications·Lei LiXiangdong Kong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
A M M SadeghiH E Junginger
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
Giuseppina SandriCarla Caramella
© 2021 Meta ULC. All rights reserved